HP (HPQ) Falls More Steeply Than Broader Market: What Investors Need to Know

HP (HPQ) closed down 1.96% at $26.47, though it has outperformed the S&P 500 over the past month with a 6.26% gain. Ahead of its August 27, 2025 earnings report, analysts project a 10.84% year-over-year decline in EPS to $0.74, contrasting with an expected 2.42% revenue increase to $13.85 billion. The stock trades at a forward P/E of 8.74, a discount to its industry average, and maintains a Zacks Rank of #3 (Hold), signaling a neutral short-term outlook despite its industry's strong performance.

Analysis

HP Inc. (HPQ) presents a mixed investment profile characterized by conflicting performance metrics and valuation signals. While the stock has demonstrated strong recent momentum, appreciating 6.26% over the past month and outperforming both the S&P 500 and its sector, it underperformed in the latest session with a 1.96% loss. The primary concern stems from forward-looking estimates ahead of its August 27, 2025, earnings report. Analysts forecast a significant divergence between top-line and bottom-line growth, with revenue projected to increase 2.42% to $13.85 billion for the quarter, while earnings per share are expected to decline 10.84% to $0.74. This pattern, mirrored in full-year estimates, points toward significant margin compression. On a valuation basis, HPQ's forward P/E ratio of 8.74 appears attractive, marking a discount to its industry's average of 12.79. However, this is countered by a less favorable PEG ratio of 2.19, which is substantially higher than the industry average of 1.53, suggesting the stock may be overvalued relative to its near-term earnings growth prospects. The neutral Zacks Rank of #3 (Hold) and steady analyst revisions further reinforce a cautious outlook, despite the company operating in a highly-ranked industry (top 6%).

Key Decisions for Investors

• Investors should scrutinize the upcoming earnings report for any guidance on margin improvement, as the current divergence between positive revenue growth and negative earnings projections is a primary risk factor.
• Consider the conflicting valuation metrics; while the low forward P/E of 8.74 suggests a potential value play, the high PEG ratio of 2.19 indicates the price may not be justified by the expected earnings decline.
• Given the neutral 'Hold' rating from Zacks and steady analyst estimates, a neutral stance may be warranted until the company provides more clarity on its ability to manage costs and restore profitability growth.